Explainer
GHK-Cu history: from a 1973 plasma study to a skincare ingredient
Prepared by: Research Desk. Sources are linked for verification.
The history of GHK-Cu is a story about how a molecule's meaning changes as it moves between research settings. GHK began as an unexplained factor in human blood plasma. It then became a copper-binding curiosity, a subject of cell-culture work on collagen and a topic for gene-expression reviews. Today it is an ingredient listed as copper tripeptide-1 on cosmetic labels. At each stage the questions, the methods and the strength of the evidence were different.
This explainer follows that path in order. For each milestone we note the kind of evidence involved: cell culture, biochemical assay, animal work, computational analysis or review. For a broader overview of mechanisms and the current evidence, see our researcher's guide to GHK-Cu.
Why the origin story matters
Marketing copy often compresses five decades of research into one sentence. A typical example is "a natural peptide that declines with age and restores youthful skin." Each part of that sentence comes from a different period, a different research group and a different type of evidence. Once the timeline is separated out, it is easier to see which claims rest on direct human measurement. It also shows which claims are extrapolations from a petri dish or a dataset.
1973: a factor in human plasma
In their reviews, Loren Pickart and colleagues describe the tripeptide glycyl-L-histidyl-L-lysine as first identified in human plasma in 1973 [1]. They say it came out of work on a plasma fraction that influenced the behaviour of liver cells in culture. The same group later described GHK as naturally present in plasma, saliva and urine, with reported levels declining with age [2].
Two points of context are useful. First, these accounts are retrospective. They were written decades later by the discoverer's own group, not by independent historians of science. Second, the age-related decline is a descriptive observation about concentrations. It does not show that the decline causes any feature of skin ageing. Nor does it show that adding GHK back to skin would change such features. The popular "replacement" argument stretches the original finding further than it can support.
The copper connection
A defining chemical feature of GHK is its high affinity for copper(II) ions. The 2008 review on tissue remodelling presents the GHK-copper complex as central to the peptide's proposed biological roles. It frames GHK as a molecule that can bind copper and may help regulate copper availability to cells [1]. This is why research and cosmetic literature so often write "GHK-Cu" rather than "GHK". The complex, not the bare peptide, is the form most studies discuss.
Coordination chemistry did not stop with the early work. In 2020, Bossak-Ahmad and colleagues characterised a ternary complex formed between Cu(II), GHK and cis-urocanic acid. They proposed it as a potential physiologically functional copper chelate [5]. Work like this is a reminder that "GHK-Cu" in a living system may not be a single, fixed species. Its chemistry may depend on what other molecules are nearby. That question matters to formulators as much as to biologists.
1988: collagen synthesis in fibroblast cultures
The finding most often linked to cosmetic interest came in 1988. Maquart and colleagues reported that the GHK-copper complex stimulated collagen synthesis in fibroblast cultures [3]. This was a cell-culture study. It measured collagen production by isolated cells grown in a dish.
The result became a cornerstone of later skincare narratives, but its scope is narrow. Fibroblasts in culture receive the compound directly in their medium. In intact skin, a topically applied molecule must first cross the stratum corneum. It must also stay chemically stable in a formulation and reach the dermis at a meaningful concentration. The 1988 study did not address any of those steps, and it was never designed to.
1990: copper, iron and lipid peroxidation
A second line of laboratory work looked at oxidative chemistry. Miller and colleagues examined the effects of the GHK-Cu complex on ferritin-dependent lipid peroxidation [4]. This was a biochemical study of how the complex interacts with iron-driven oxidative reactions. It was not a study of human skin. It helped seed the "protective" or antioxidant framing that appears in later reviews. One example is the 2012 paper on oxidative stress and degenerative conditions of ageing, which extended the discussion to cognitive health [6].
2008 onward: the tissue-remodelling synthesis
By 2008, the Pickart group had gathered several decades of cell and animal research into one model. In that model, GHK acts as a signal involved in tissue remodelling, including in wound-repair settings [1]. Reviews like this are useful maps of a field. But they summarise work of mixed types, much of it preclinical. They are syntheses, not new experiments, and their conclusions are only as strong as the studies underneath them.
The 2010s: gene-expression data reframes the story
The next major shift was computational. In 2014 and 2018, Pickart and colleagues analysed publicly available gene-expression data. They reported that GHK was associated with changes in the expression of a large number of human genes [7][8]. A 2015 review placed these findings alongside earlier skin research, describing GHK as a modulator of multiple cellular pathways in skin regeneration [2].
This era produced the most quoted claims in modern marketing, such as GHK "resetting" thousands of genes. Three caveats apply:
The data come from cell lines. Expression profiles from cultured cells do not show what happens in intact human skin after topical application.
Expression change is not outcome. A shift in messenger RNA levels does not by itself show a change in tissue structure or function.
Interpretive titles are not findings. Words such as "resetting the human genome to health" in a paper's title describe the authors' interpretation. They are not a measured endpoint [7].
From laboratory molecule to cosmetic label
Over time, GHK-Cu moved from the research literature into cosmetic formulations under the INCI name copper tripeptide-1. That move happened within a specific regulatory frame. In the United States, the FDA classifies a product as a cosmetic or a drug by its intended use, which is shown largely by the claims made for it [11]. The same ingredient can sit in either category depending on how the product is marketed.
The Modernization of Cosmetics Regulation Act of 2022 later added duties for cosmetic companies. These include facility registration, product listing, adverse-event reporting and safety substantiation. None of these amounts to pre-market approval [12]. Our explainer on GHK-Cu's legal and FDA status covers how route of use changes the picture.
Independent voices and newer methods
For much of its history, the review literature on GHK was dominated by one research group. That is common for a molecule tied to a single discoverer, but it is worth noticing. A 2020 review by Dou and colleagues, a different author group, assessed the potential of GHK as an anti-ageing peptide [9]. It adds an outside perspective, although it is still a review rather than primary data.
The newest chapter is methodological. In 2025, Ogórek and colleagues asked whether researchers are ready to measure skin permeation of GHK-Cu encapsulated in liposomes [10]. The framing of that question says a lot. Fifty years after the plasma finding, how well the molecule gets through skin, and how to measure it, is still an open research problem.
Timeline at a glance
Period | Milestone | Evidence type | Source |
|---|---|---|---|
1973 | GHK identified in human plasma (as recounted in later reviews) | Laboratory isolation; retrospective account | [1] |
1988 | Collagen synthesis reported in fibroblast cultures | Cell culture | [3] |
1990 | Effects on ferritin-dependent lipid peroxidation examined | Biochemical assay | [4] |
2008 | Tissue-remodelling synthesis published | Review | [1] |
2012 | Oxidative-stress and cognitive-health framing | Review | [6] |
2014–2018 | Gene-expression analyses reported | Computational analysis of public data; review | [7][8] |
2015 | Skin-pathway synthesis | Review | [2] |
2020 | Ternary copper complex characterised; independent review | Chemistry study; review | [5][9] |
2025 | Methods for measuring permeation of liposomal GHK-Cu examined | Methods study | [10] |
Frequently asked questions
Who discovered GHK-Cu?
Published reviews credit Loren Pickart, who first described the tripeptide GHK in human plasma in 1973 [1]. Its strong affinity for copper(II) later led research to focus on the GHK-Cu complex.
Was GHK-Cu first developed as a skincare ingredient?
No. It began as a subject of basic research into a plasma factor and only later entered cosmetic formulations. Its cosmetic profile drew heavily on laboratory findings, such as the 1988 fibroblast collagen study [3], rather than on studies first designed around topical products.
Does the gene-expression research show what GHK-Cu does in human skin?
Not directly. The gene-expression reports came from analyses of cell-line data [7][8]. They do not measure what happens in intact skin after a product is applied. The 2025 work on permeation methods shows that even delivery into skin is still being worked out [10].
Further reading: choosing books on cosmetic science and its history
A history like this one is easier to judge when you understand how cosmetic chemistry and laboratory science work in general. A good book can save hours of piecing together scattered papers. It also makes it easier to spot when a marketing claim has drifted away from its evidence.
When comparing titles, these neutral criteria separate useful books from glossy ones:
Sourcing: look for endnotes or references to primary literature, not just a bibliography of other popular books.
Currency: check the edition and publication date, especially for anything covering regulation, which changed substantially in 2022.
Author background: formulation chemists, analytical scientists and historians of science each bring a different and useful lens.
Scope and level: decide whether you need an introductory survey, a formulator's technical reference or a narrative history of laboratory discovery.
Format and price transparency: compare print, e-book and audio editions, and check whether figures and tables survive in the digital version.
For most readers, the best pairing is one technical cosmetic-science reference and one well-sourced history-of-science narrative. Together they cover how ingredients are made and tested, and how scientific claims evolve over decades.
Our selection process, sourcing standards and full disclosures are explained on the About page.
Last updated: 19 October 2026.
Related on this site
Copper peptides vs retinol: what the research actually compares
Copper peptides and vitamin C: what the formulation research says
Not medical advice. This page reports published research and regulatory records for information only.
Research-only notice: Content on this site is provided for research and educational purposes only and is not intended for human use. It is not medical advice.
Translation notice: Some content on this site may have been machine-translated using Google Translate and may contain errors.
Sources
Prepared by
Research Desk